89Zr-Trastuzumab PET/CT Imaging of HER2-Positive Breast Cancer for Predicting Pathological Complete Response after Neoadjuvant Systemic Therapy: A Feasibility Study
D. G.J. Linders*, M. M. Deken, M. A. van Dam, M. N.J.M. Wasser, E. M.C. Voormolen, J. R. Kroep, G. A.M.S. van Dongen, D. Vugts, L. F. de Geus-Oei, More Authors
Research output: Contribution to journal › Article › Scientific › peer-review
37Downloads
(Pure)
Fingerprint
Dive into the research topics of '89Zr-Trastuzumab PET/CT Imaging of HER2-Positive Breast Cancer for Predicting Pathological Complete Response after Neoadjuvant Systemic Therapy: A Feasibility Study'. Together they form a unique fingerprint.